Overview

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
This study compared the rates and extents of medroxyprogesterone absorption from two medroxyprogesterone acetate injection formulations following single 150 mg intramuscular (IM) injections to healthy postmenopausal women.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Medroxyprogesterone
Medroxyprogesterone Acetate